The expression of thyroid hormone transporters in the human fetal cerebral cortex during early development and in N-Tera-2 neurodifferentiation

Journal of Physiology

Volumn 589, Issue 11, 2011, Pages 2827-2845

  Chan, S Y ^a   Martin Santos A ^a   Loubiere L S ^a   Gonzalez A M ^a   Stieger, B ^b   Logan, A ^a   Mccabe, C J ^a   Franklyn, J A ^a   Kilby, M D ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER 1; AMINO ACID TRANSPORTER 2; CARRIER PROTEIN; CD98 ANTIGEN; LIOTHYRONINE; MESSENGER RNA; MONOCARBOXYLATE TRANSPORTER 10; MONOCARBOXYLATE TRANSPORTER 8; ORGANIC ANION TRANSPORTER 1A2; ORGANIC ANION TRANSPORTER 1C1; ORGANIC ANION TRANSPORTER 3A1; ORGANIC ANION TRANSPORTER 4A1; RETINOIC ACID; THYROID HORMONE; THYROID HORMONE TRANSPORTER; UNCLASSIFIED DRUG;

ARTICLE; BRAIN CELL; BRAIN CORTEX; BRAIN DEVELOPMENT; CELL LINE; CELL STRAIN N TERA 2; CONTROLLED STUDY; FETUS; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HORMONE TRANSPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROVASCULATURE; NERVE CELL DIFFERENTIATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM;

ABORTED FETUS; AMINO ACID TRANSPORT SYSTEM Y+; AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; ANTIGENS, CD98; ANTIGENS, CD98 LIGHT CHAINS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; CEREBRAL CORTEX; GENE EXPRESSION; GESTATIONAL AGE; HUMANS; INTERMEDIATE FILAMENT PROTEINS; LARGE NEUTRAL AMINO ACID-TRANSPORTER 1; MONOCARBOXYLIC ACID TRANSPORTERS; NERVE TISSUE PROTEINS; NEUROFILAMENT PROTEINS; NEURONS; OCTAMER TRANSCRIPTION FACTOR-3; ORGANIC ANION TRANSPORTERS; PLURIPOTENT STEM CELLS; RNA, SMALL INTERFERING; THYROID HORMONES; TRETINOIN; TRIIODOTHYRONINE;

EID: 79957843158     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.207290     Document Type: Article

References (72)

1. Ahmed Z, Dent RG, Suggate EL, Barrett LB, Seabright RJ, Berry M & Logan A (2005). Disinhibition of neurotrophin-induced dorsal root ganglion cell neurite outgrowth on CNS myelin by siRNA-mediated knockdown of NgR, p75(NTR) and Rho-A. Mol Cell Neurosci 28, 509-523.
2. Andersen CL, Jensen JL & Orntoft TF (2004). Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64, 5245-5250.
3. Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli NC & Fogh J (1984). Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest 50, 147-162.
4. Benvenuti S, Luciani P, Cellai I, Deledda C, Baglioni S, Saccardi R, Urbani S, Francini F, Squecco R, Giuliani C, Vannelli GB, Serio M, Pinchera A & Peri A (2008). Thyroid hormones promote cell differentiation and up-regulate the expression of the seladin-1 gene in in vitro models of human neuronal precursors. J Endocrinol 197, 437-446.
5. Blondeau JP, Beslin A, Chantoux F & Francon J (1993). Triiodothyronine is a high-affinity inhibitor of amino acid transport system L1 in cultured astrocytes. J Neurochem 60, 1407-1413.
6. Broer A, Wagner CA, Lang F & Broer S (2000). The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux in exchange with glutamine. Biochem J 349(Pt 3), 787-795.
7. Bronger H, Konig J, Kopplow K, Steiner HH, Ahmadi R, Herold-Mende C, Keppler D & Nies AT (2005). ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. Cancer Res 65, 11419-11428.
8. Calvo RM, Jauniaux E, Gulbis B, Asuncion M, Gervy C, Contempre B & Morreale dE (2002). Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 87, 1768-1777.
9. Capelo LP, Beber EH, Fonseca TL & Gouveia CH (2009). The monocarboxylate transporter 8 and L-type amino acid transporters 1 and 2 are expressed in mouse skeletons and in osteoblastic MC3T3-E1 cells. Thyroid 19, 171-180.
10. Ceballos A, Belinchon MM, Sanchez-Mendoza E, Grijota-Martinez C, Dumitrescu AM, Refetoff S, Morte B & Bernal J (2009). Importance of monocarboxylate transporter 8 for the blood-brain barrier-dependent availability of 3, 5, 3'-triiodo-L-thyronine. Endocrinology 150, 2491-2496.
11. Chan S, Kachilele S, McCabe C, Tannahill L, Boelaert K, Gittoes N, Visser T, Franklyn J & Kilby M (2002). Early expression of thyroid hormone deiodinases and receptors in human fetal cerebral cortex. Brain Res Dev Brain Res 138, 109-116.
12. Chan S, McCabe CJ, Visser TJ, Franklyn JA & Kilby MD (2003). Thyroid hormone responsiveness in N-Tera-2 cells. J Endocrinol 178, 159-167.
13. Chan SY, Franklyn JA, Pemberton HN, Bulmer JN, Visser TJ, McCabe CJ & Kilby D (2006). Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction. J Endocrinol 189, 465-471.
14. Choudhuri S, Cherrington NJ, Li N & Klaassen CD (2003). Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. Drug Metab Dispos 31, 1337-1345.
15. de Escobar GM, Obregon MJ & del Rey FE (2004). Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab 18, 225-248.
16. Dowling AL, Martz GU, Leonard JL & Zoeller RT (2000). Acute changes in maternal thyroid hormone induce rapid and transient changes in gene expression in fetal rat brain. J Neurosci 20, 2255-2265.
17. Dratman MB, Crutchfield FL & Schoenhoff MB (1991). Transport of iodothyronines from bloodstream to brain: contributions by blood:brain and choroid plexus:cerebrospinal fluid barriers. Brain Res 554, 229-236.
18. Dumitrescu AM, Liao XH, Best TB, Brockmann K & Refetoff S (2004). A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 74, 168-175.
19. Fliers E, Unmehopa UA & Alkemade A (2006). Functional neuroanatomy of thyroid hormone feedback in the human hypothalamus and pituitary gland. Mol Cell Endocrinol 251, 1-8.
20. Friesema EC, Docter R, Moerings EP, Verrey F, Krenning EP, Hennemann G & Visser TJ (2001). Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinology 142, 4339-4348.
21. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP & Visser TJ (2003). Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278, 40128-40135.
22. Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH & Visser TJ (2008). Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol 22, 1357-1369.
23. Friesema ECH, Grueters A, Biebermann H, Krude H, von Moers A, Reeser M, Barrett TG, Mancilla EE, Svensson J, Kester MHA, Kuiper GGJM, Balkassmi S, Uitterlinden AG, Koehrle J, Rodien P, Halestrap AP & Visser T (2004). Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 364, 1435-1437.
24. Fujiwara K, Adachi H, Nishio T, Unno M, Tokui T, Okabe M, Onogawa T, Suzuki T, Asano N, Tanemoto M, Seki M, Shiiba K, Suzuki M, Kondo Y, Nunoki K, Shimosegawa T, Iinuma K, Ito S, Matsuno S & Abe T (2001). Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner. Endocrinology 142, 2005-2012.
25. Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A & Meier PJ (2000). Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J Pharmacol Exp Ther 294, 73-79.
26. Gao B, Huber RD, Wenzel A, Vavricka SR, Ismair MG, Reme C & Meier PJ (2005). Localization of organic anion transporting polypeptides in the rat and human ciliary body epithelium. Exp Eye Res 80, 61-72.
27. Garcia-Silva S, Perez-Juste G & Aranda A (2002). Cell cycle control by the thyroid hormone in neuroblastoma cells. Toxicology 181-182, 179-182.
28. Gilbert ME & Paczkowski C (2003). Propylthiouracil (PTU)-induced hypothyroidism in the developing rat impairs synaptic transmission and plasticity in the dentate gyrus of the adult hippocampus. Dev Brain Res 145, 19-29.
29. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O'Heir CE, Mitchell ML, Hermos RJ, Waisbren SE, Faix JD & Klein RZ (1999). Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341, 549-555.
30. Hara K, Yasuhara T, Maki M, Matsukawa N, Masuda T, Yu SJ, Ali M, Yu G, Xu L, Kim SU, Hess DC & Borlongan CV (2008). Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. Prog Neurobiol 85, 318-334.
31. Heckel T, Broer A, Wiesinger H, Lang F & Broer S (2003). Asymmetry of glutamine transporters in cultured neural cells. Neurochem Int 43, 289-298.
32. Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP & Visser TJ (2001). Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev 22, 451-476.
33. Heuer H (2007). The importance of thyroid hormone transporters for brain development and function. Best Pract Res Clin Endocrinol Metab 21, 265-276.
34. Heuer H, Maier MK, Iden S, Mittag J, Friesema ECH, Visser TJ & Bauer K (2005). The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology 146, 1701-1706.
35. Heuer H & Mason CA (2003). Thyroid hormone induces cerebellar Purkinje cell dendritic development via the thyroid hormone receptor alpha1. J Neurosci 23, 10604-10612.
36. Horn S & Heuer H (2010). Thyroid hormone action during brain development: more questions than answers. Mol Cell Endocrinol 315, 19-26.
37. Howard B, Chen Y & Zecevic N (2006). Cortical progenitor cells in the developing human telencephalon. Glia 53, 57-66.
38. Huber RD, Gao B, Sidler Pfandler MA, Zhang-Fu W, Leuthold S, Hagenbuch B, Folkers G, Meier PJ & Stieger B (2007). Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain. Am J Physiol Cell Physiol 292, C795-C806.
39. James SR, Franklyn JA, Reaves BJ, Smith VE, Chan SY, Barrett TG, Kilby MD & McCabe CJ (2009). Monocarboxylate transporter 8 in neuronal cell growth. Endocrinology 150, 1961-1969.
40. Jones SA, Jolson DM, Cuta KK, Mariash CN & Anderson GW (2003). Triiodothyronine is a survival factor for developing oligodendrocytes. Mol Cell Endocrinol 199, 49-60.
41. Kester MHA, de Mena RM, Obregon MJ, Marinkovic D, Howatson A, Visser TJ, Hume R & de Escobar GM (2004). Iodothyronine levels in the human developing brain: Major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab 89, 3117-3128.
42. Kido Y, Tamai I, Uchino H, Suzuki F, Sai Y & Tsuji A (2001). Molecular and functional identification of large neutral amino acid transporters LAT1 and LAT2 and their pharmacological relevance at the blood-brain barrier. J Pharm Pharmacol 53, 497-503.
43. Kilby MD, Gittoes N, McCabe C, Verhaeg J & Franklyn JA (2000). Expression of thyroid receptor isoforms in the human fetal central nervous system and the effects of intrauterine growth restriction. Clin Endocrinol (Oxf) 53, 469-477.
44. Kinne A, Kleinau G, Hoefig CS, Gruters A, Kohrle J, Krause G & Schweizer U (2010). Essential molecular determinants for thyroid hormone transport and first structural implications for monocarboxylate transporter 8. J Biol Chem 285, 28054-28063.
45. Kogai T, Liu YY, Richter LL, Mody K, Kagechika H & Brent GA (2010). Retinoic acid induces expression of the thyroid hormone transporter, monocarboxylate transporter 8 (Mct8). J Biol Chem 285, 27279-27288.
46. Lavado-Autric R, Auso E, Garcia-Velasco JV, Arufe MD, del Rey FE, Berbel P & de Escobar GM (2003). Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. J Clin Invest 111, 1073-1082.
47. Loubiere LS, Vasilopoulou E, Bulmer JN, Taylor PM, Stieger B, Verrey F, McCabe CJ, Franklyn JA, Kilby MD & Chan SY (2010). Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction. Placenta 31, 295-304.
48. Mebis L, Debaveye Y, Ellger B, Derde S, Ververs EJ, Langouche L, Darras VM, Fliers E, Visser TJ & Van den BG (2009). Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness. Crit Care 13, R147.
49. Morte B, Ceballos A, Diez D, Grijota-Martinez C, Dumitrescu AM, Di CC, Galton VA, Refetoff S & Bernal J (2010). Thyroid hormone-regulated mouse cerebral cortex genes are differentially dependent on the source of the hormone: a study in monocarboxylate transporter-8- and deiodinase-2-deficient mice. Endocrinology 151, 2381-2387.
50. Pizzagalli F, Hagenbuch B, Stieger B, Klenk U, Folkers G & Meier PJ (2002). Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Mol Endocrinol 16, 2283-2296.
51. Pleasure SJ, Page C & Lee VM (1992). Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 12, 1802-1815.
52. Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL & de Vijlder JJ (2003). Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf) 59, 282-288.
53. Przyborski SA, Smith S & Wood A (2003). Transcriptional profiling of neuronal differentiation by human embryonal carcinoma stem cells in vitro. Stem Cells 21, 459-471.
54. Ramadan T, Camargo SM, Herzog B, Bordin M, Pos KM & Verrey F (2007). Recycling of aromatic amino acids via TAT1 allows efflux of neutral amino acids via LAT2-4F2hc exchanger. Pflugers Arch 454, 507-516.
55. Ramadan T, Camargo SMR, Summa V, Hunziker P, Chesnov S, Pos KM & Verrey F (2006). Basolateral aromatic amino acid transporter TAT1 (Slc16A10) functions as an efflux pathway. J Cell Physiol 206, 771-779.
56. Reichel C, Gao B, Van MJ, Cattori V, Rahner C, Hagenbuch B, Stieger B, Kamisako T & Meier PJ (1999). Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver. Gastroenterology 117, 688-695.
57. Ritchie JW & Taylor PM (2001). Role of the System L permease LAT1 in amino acid and iodothyronine transport in placenta. Biochem J 356, 719-725.
58. Roberts LM, Woodford K, Zhou M, Black DS, Haggerty JE, Tate EH, Grindstaff KK, Mengesha W, Raman C & Zerangue N (2008). Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier. Endocrinology 149, 6251-6261.
59. Schwartz CE, May MM, Carpenter NJ, Rogers RC, Martin J, Bialer MG, Ward J, Sanabria J, Marsa S, Lewis JA, Echeverri R, Lubs HA, Voeller K, Simensen RJ & Stevenson RE (2005). Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am J Hum Genet 77, 41-53.
60. Sugiura M, Nagaoka M, Yabuuchi H & Akaike T (2007). Overexpression of MCT8 enhances the differentiation of ES cells into neural progenitors. Biochem Biophys Res Commun 360, 741-745.
61. Sugiyama D, Kusuhara H, Taniguchi H, Ishikawa S, Nozaki Y, Aburatani H & Sugiyama Y (2003). Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood-brain barrier: high affinity transporter for thyroxine. J Biol Chem 278, 43489-43495.
62. Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M & Tsuji A (2000). Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun 273, 251-260.
63. Tohyama K, Kusuhara H & Sugiyama Y (2004). Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology 145, 4384-4391.
64. Trajkovic M, Visser TJ, Mittag J, Horn S, Lukas J, Darras VM, Raivich G, Bauer K & Heuer H (2007). Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J Clin Invest 117, 627-635.
65. Trojanowski JQ, Kleppner SR, Hartley RS, Miyazono M, Fraser NW, Kesari S & Lee VM (1997). Transfectable and transplantable postmitotic human neurons: a potential 'platform' for gene therapy of nervous system diseases. Exp Neurol 144, 92-97.
66. Tu HM, Legradi G, Bartha T, Salvatore D, Lechan RM & Larsen PR (1999). Regional expression of the type 3 iodothyronine deiodinase messenger ribonucleic acid in the rat central nervous system and its regulation by thyroid hormone. Endocrinology 140, 784-790.
67. Vasilopoulou E, Loubiere LS, Martin-Santos A, McCabe CJ, Franklyn JA, Kilby MD & Chan SY (2010). Differential triiodothyronine responsiveness and transport by human cytotrophoblasts from normal and growth-restricted pregnancies. J Clin Endocrinol Metab 95, 4762-4770.
68. Virgintino D, Errede M, Robertson D, Capobianco C, Girolamo F, Vimercati A, Bertossi M & Roncali L (2004). Immunolocalization of tight junction proteins in the adult and developing human brain. Histochem Cell Biol 122, 51-59.
69. Visser TJ, Leonard JL, Kaplan MM & Larsen PR (1982). Kinetic evidence suggesting two mechanisms for iodothyronine 5'- deiodination in rat cerebral cortex. Proc Natl Acad Sci U S A 79, 5080-5084.
70. Visser WE, Philp NJ, van Dijk TB, Klootwijk W, Friesema EC, Jansen J, Beesley PW, Ianculescu AG & Visser TJ (2009). Evidence for a homodimeric structure of human monocarboxylate transporter 8. Endocrinology 150, 5163-5170.
71. Wirth EK, Roth S, Blechschmidt C, Holter SM, Becker L, Racz I, Zimmer A, Klopstock T, Gailus-Durner V, Fuchs H, Wurst W, Naumann T, Brauer A, de Angelis MH, Kohrle J, Gruters A & Schweizer U (2009). Neuronal 3', 3, 5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. J Neurosci 29, 9439-9449.
72. Zlender V, Breljak D, Ljubojevic M, Flajs D, Balen D, Brzica H, Domijan AM, Peraica M, Fuchs R, Anzai N & Sabolic I (2009). Low doses of ochratoxin A upregulate the protein expression of organic anion transporters Oat1, Oat2, Oat3 and Oat5 in rat kidney cortex. Toxicol Appl Pharmacol 239, 284-296.